Please use this identifier to cite or link to this item:
https://hdl.handle.net/11147/14371
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Inci, Orhan Kerim | - |
dc.contributor.author | Basirli, Hande | - |
dc.contributor.author | Can, Melike | - |
dc.contributor.author | Yanbul, Selman | - |
dc.contributor.author | Seyrantepe, Volkan | - |
dc.date.accessioned | 2024-05-05T14:57:05Z | - |
dc.date.available | 2024-05-05T14:57:05Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 2090-3030 | - |
dc.identifier.issn | 2090-3049 | - |
dc.identifier.uri | https://doi.org/10.1155/2024/4530255 | - |
dc.identifier.uri | https://hdl.handle.net/11147/14371 | - |
dc.description.abstract | Gangliosides, sialic acid-containing glycosphingolipids, are abundant in cell membranes and primarily involved in controlling cell signaling and cell communication. The altered ganglioside pattern has been demonstrated in several neurodegenerative diseases, characterized during early-onset or infancy, emphasizing the significance of gangliosides in the brain. Enzymes required for the biosynthesis of gangliosides are linked to several devastating neurological disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegia (HSP). In this review, we summarized not only the critical roles of biosynthetic enzymes and their inhibitors in ganglioside metabolism but also the efficacy of treatment strategies of ganglioside to address their significance in those diseases. | en_US |
dc.description.sponsorship | Trkiye Bilimsel ve Teknolojik Arascedil;tirma Kurumu [218S824, 120N552]; Scientific and Technological Research Council of Turkey (TUBITAK) | en_US |
dc.description.sponsorship | This study was partially funded by the Scientific and Technological Research Council of Turkey (TUBITAK) (Grants 218S824 and 120N552). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Hindawi Ltd | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | [No Keyword Available] | en_US |
dc.title | Gangliosides as Therapeutic Targets for Neurodegenerative Diseases | en_US |
dc.type | Review | en_US |
dc.department | Izmir Institute of Technology | en_US |
dc.identifier.volume | 2024 | en_US |
dc.identifier.wos | WOS:001205917200001 | - |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.doi | 10.1155/2024/4530255 | - |
dc.identifier.pmid | 38623278 | - |
dc.identifier.scopusquality | N/A | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Review | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | 04.03. Department of Molecular Biology and Genetics | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.